Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-25-020627
Filing Date
2025-11-03
Accepted
2025-11-03 17:09:59
Documents
5

Document Format Files

Seq Description Document Type Size
1 DEFA14A formdefa14a.htm DEFA14A 27978
2 GRAPHIC formdefa14a_001.jpg GRAPHIC 464515
3 GRAPHIC formdefa14a_002.jpg GRAPHIC 230213
4 GRAPHIC formdefa14a_003.jpg GRAPHIC 519264
5 GRAPHIC formdefa14a_004.jpg GRAPHIC 309421
  Complete submission text file 0001493152-25-020627.txt   2127708
Mailing Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477
Business Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477 203-434-3290
Greenwich LifeSciences, Inc. (Filer) CIK: 0001799788 (see all company filings)

EIN.: 205473709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39555 | Film No.: 251445152
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)